figshare
Browse
12967_2021_3189_MOESM2_ESM.pptx (153.27 kB)

Additional file 2 of Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development

Download (153.27 kB)
presentation
posted on 2021-12-21, 04:27 authored by Elaine Mai, Joyce Chan, Levina Goon, Braeden K. Ego, Jack Bevers, Tiffany Wong, Manda Wong, Racquel Corpuz, Hongkang Xi, Jia Wu, Kellen Schneider, Dhaya Seshasayee, Michele Grimbaldeston, Gerald Nakamura, Vahan B. Indjeian, Menno van Lookeren Campagne, Kelly M. Loyet, Laetitia Comps-Agrar
Additional file 2: Figure S2. Reduced and oxidized hIL-33 QC (A) SDS-PAGE gel analysis of hIL-33 diluted in either PBS (a) or 60% IMDM media (b) and incubated at 37 °C. Shown are samples taken at t = 0 and t = 18 h time intervals. The protein samples were run under non-reducing conditions and reducing conditions with dithiothreitol (DTT). Molecular weight standards were applied in lanes 3, 6 and 9. (B) Mass spectrometry analysis of hIL-33 incubated at 37 °C in (a) PBS at t = 0, (b) PBS at t = 18 h and (c) IMDM media at t = 18 h. The detected MW’s for hIL-33 in each spectrum are shown. The theoretical MW of hIL-33 with all of its 4 cysteine residues fully reduced is 19857.19 dalton (Da). For a fully oxidized hIL-33, the theoretical molecular weight (MW) with all 4 cysteines forming two intra-disulfide bonds is 19853.16 Da. Panels (a) and (b) show hIL-33 with its cysteine residues in a fully reduced state while panel (c) shows the hIL-33’s cysteine residues in an oxidized state.

Funding

Genentech

History

Usage metrics

    Journal of Translational Medicine

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC